Sam-A Pharm Co Ltd
KOSDAQ:009300
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sam-A Pharm Co Ltd
KOSDAQ:009300
|
KR |
|
H
|
Hormel Foods Corp
F:HO7
|
US |
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
P
|
Paladin Energy Ltd
OTC:PALAF
|
AU |
|
M
|
Multistack International Ltd
ASX:MSI
|
AU |
|
D
|
Deutsche Boerse AG
XMUN:DB1
|
DE |
Intrinsic Value
Is Sam-A Pharm Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Sam-A Pharm Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Sam-A Pharm Does
Sam-A Pharm Co Ltd is a South Korean pharmaceutical company that makes and sells medicines and drug ingredients. Its business is centered on developing finished drugs and active pharmaceutical ingredients, which are the core chemical inputs used to make medicines. It supplies these products to hospitals, clinics, pharmacies, and other drug companies that need reliable ingredients or ready-to-use treatments.
- Headquarters
- Korea KR
- IPO date
- Jul 19, 2000
Revenue & Expenses Breakdown
Sam-A Pharm Co Ltd
Earnings Waterfall
Sam-A Pharm Co Ltd
The intrinsic value for Sam-A Pharm Co Ltd (009300) under the Base Case is hidden KRW.
Compared with the current market price of 13 530 KRW, the stock appears hidden.